75 related articles for article (PubMed ID: 17218947)
1. The use of tissue inhibitors of matrix metalloproteinases to increase the efficacy of a tumor necrosis factor/interferon gamma antitumor therapy.
Van Roy M; Wielockx B; Baker A; Libert C
Cancer Gene Ther; 2007 Apr; 14(4):372-9. PubMed ID: 17218947
[TBL] [Abstract][Full Text] [Related]
2. Protection of zinc against tumor necrosis factor induced lethal inflammation depends on heat shock protein 70 and allows safe antitumor therapy.
Van Molle W; Van Roy M; Van Bogaert T; Dejager L; Van Lint P; Vanlaere I; Sekikawa K; Kollias G; Libert C
Cancer Res; 2007 Aug; 67(15):7301-7. PubMed ID: 17671199
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinases-1 in the liver: efficient protection against T-cell lymphoma and colon carcinoma metastasis.
Elezkurtaj S; Kopitz C; Baker AH; Perez-Cantó A; Arlt MJ; Khokha R; Gansbacher B; Anton M; Brand K; Krüger A
J Gene Med; 2004 Nov; 6(11):1228-37. PubMed ID: 15390257
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective effect of adenoviral-mediated gene transfer of TIMP-1 and -2 in ischemic brain injury.
Magnoni S; Baker A; Thomson S; Jordan G; George SJ; McColl BW; McCulloch J; Horsburgh K
Gene Ther; 2007 Apr; 14(7):621-5. PubMed ID: 17235293
[TBL] [Abstract][Full Text] [Related]
5. Induction of tolerance allows separation of lethal and antitumor activities of tumor necrosis factor in mice.
Takahashi N; Brouckaert P; Fiers W
Cancer Res; 1991 May; 51(9):2366-72. PubMed ID: 1826631
[TBL] [Abstract][Full Text] [Related]
6. Targeted delivery of IFNgamma to tumor vessels uncouples antitumor from counterregulatory mechanisms.
Curnis F; Gasparri A; Sacchi A; Cattaneo A; Magni F; Corti A
Cancer Res; 2005 Apr; 65(7):2906-13. PubMed ID: 15805293
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated delivery of human IFNgamma gene inhibits prostate cancer growth.
Zhao P; Zhu YH; Wu JX; Liu RY; Zhu XY; Xiao X; Li HL; Huang BJ; Xie FJ; Chen JM; Ke ML; Huang W
Life Sci; 2007 Aug; 81(9):695-701. PubMed ID: 17714738
[TBL] [Abstract][Full Text] [Related]
8. Involvement of specific matrix metalloproteinases during tumor necrosis factor/IFNgamma-based cancer therapy in mice.
Van Roy M; Van Lint P; Van Laere I; Wielockx B; Wilson C; López-Otin C; Shapiro S; Libert C
Mol Cancer Ther; 2007 Sep; 6(9):2563-71. PubMed ID: 17876053
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy.
Wielockx B; Lannoy K; Shapiro SD; Itoh T; Itohara S; Vandekerckhove J; Libert C
Nat Med; 2001 Nov; 7(11):1202-8. PubMed ID: 11689884
[TBL] [Abstract][Full Text] [Related]
10. Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo.
Bendrik C; Robertson J; Gauldie J; Dabrosin C
Cancer Res; 2008 May; 68(9):3405-12. PubMed ID: 18451168
[TBL] [Abstract][Full Text] [Related]
11. Improving TNF as a cancer therapeutic: tailor-made TNF fusion proteins with conserved antitumor activity and reduced systemic side effects.
Gerspach J; Pfizenmaier K; Wajant H
Biofactors; 2009; 35(4):364-72. PubMed ID: 19484741
[TBL] [Abstract][Full Text] [Related]
12. Synergy of adoptive T-cell therapy and intratumoral suicide gene therapy is mediated by host NK cells.
Sanchez-Perez L; Gough M; Qiao J; Thanarajasingam U; Kottke T; Ahmed A; Thompson JM; Maria Diaz R; Vile RG
Gene Ther; 2007 Jul; 14(13):998-1009. PubMed ID: 17443216
[TBL] [Abstract][Full Text] [Related]
13. Augmentation of antimetastatic activity of interferon and tumor necrosis factor by heparin.
Sylvester DM; Liu SY; Meadows GG
Immunopharmacol Immunotoxicol; 1990; 12(2):161-80. PubMed ID: 2121817
[TBL] [Abstract][Full Text] [Related]
14. Bcl-2 and glutathione depletion sensitizes B16 melanoma to combination therapy and eliminates metastatic disease.
Mena S; Benlloch M; Ortega A; Carretero J; Obrador E; Asensi M; Petschen I; Brown BD; Estrela JM
Clin Cancer Res; 2007 May; 13(9):2658-66. PubMed ID: 17473197
[TBL] [Abstract][Full Text] [Related]
15. Effect of low-dose tumor necrosis factor-alpha in combination with STEALTH liposomal cisplatin (SPI-077) on soft-tissue- and osteosarcoma-bearing rats.
Hoving S; van Tiel ST; Eggermont AM; ten Hagen TL
Anticancer Res; 2005; 25(2A):743-50. PubMed ID: 15868905
[TBL] [Abstract][Full Text] [Related]
16. Prolonged exposure to IL-1beta and IFNgamma induces necrosis of L929 tumor cells via a p38MAPK/NF-kappaB/NO-dependent mechanism.
Vercammen E; Staal J; Van Den Broeke A; Haegman M; Vereecke L; Schotte P; Beyaert R
Oncogene; 2008 Jun; 27(27):3780-8. PubMed ID: 18246123
[TBL] [Abstract][Full Text] [Related]
17. Desmopressin reduces melanoma lung metastasis in transgenic mice overexpressing tissue inhibitor of metalloproteinases-1.
Ripoll GV; Farina HG; Yoshiji H; Gomez DE; Alonso DF
In Vivo; 2006; 20(6B):881-5. PubMed ID: 17203783
[TBL] [Abstract][Full Text] [Related]
18. Low-dose radiation potentiates the therapeutic efficacy of folate receptor-targeted hapten therapy.
Sega EI; Lu Y; Ringor M; Leamon CP; Low PS
Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):559-66. PubMed ID: 18411004
[TBL] [Abstract][Full Text] [Related]
19. Antisense oligonucleotides against TNFR1 prevent toxicity of TNF/IFNγ treatment in mouse tumor models.
Van Hauwermeiren F; Vandenbroucke RE; Grine L; Puimège L; Van Wonterghem E; Zhang H; Libert C
Int J Cancer; 2014 Aug; 135(3):742-50. PubMed ID: 24382818
[TBL] [Abstract][Full Text] [Related]
20. Live attenuated Salmonella as a vector for oral cytokine gene therapy in melanoma.
Agorio C; Schreiber F; Sheppard M; Mastroeni P; Fernandez M; Martinez MA; Chabalgoity JA
J Gene Med; 2007 May; 9(5):416-23. PubMed ID: 17410612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
